Hongbin Ji

53PUBLICATIONS
180CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - amino acids and metabolitesMolecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Jun 18, 2026
TRIM21-mediated ubiquitination of PARP1 regulated by the PI3K/AKT-STAT5A axis suppresses small cell lung cancer.

|Apr 05, 2026
Efficacy and safety of albumin-bound paclitaxel combined with simvastatin in the second-line treatment of small cell lung cancer: a phase II randomized controlled trial.

Maoying Guan, Wencheng Zhao, Wengang Zhang

|Feb 06, 2026
SLC6A6 imports taurine into mitochondria to sustain mitochondrial translation and tumour growth.

Liucheng Li, Jianwei You, Zi-Qing Chai

|Jan 08, 2026
KMT2D loss drives adeno-to-squamous transition and sensitizes TKI-resistant lung cancer to AURKA inhibition.

Nana Chen, Mouxiang Fang, Leqi Zhong

|Dec 17, 2025
Multi-gradient permutation survival analysis identifies mitosis and immune signatures steadily associated with cancer patient prognosis.

Xinlei Cai, Yi Ye, Xiaoping Liu

|Dec 15, 2025
Concurrent PIK3CA mutant promotes cachexia through inflammatory signaling in EGFR mutant lung cancer.

Meiting Yue, Zhen Qin, Shijie Tang

Pageof 9

Frequent Collaborators

10 joint publications

Liang Hu

8 joint publications

Luonan Chen

6 joint publications

Yun Xue

5 joint publications

Xinlei Cai